🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot study evaluates the feasibility and outcomes of two treatment ap...
Status
Not Yet Recruiting
Location
Ivey Eye Institute, St. Joseph's Health Care London
Start Date
2025-08-01
Trial ID
NCT07073729
Treatments Being Tested
A prospective, longitudinal, cross-sectional, observational Study with a 8-...
Status
Completed
Location
Ophtalmology Clinic, G.d'Annunzio University
Start Date
2018-03-01
Trial ID
NCT04293549
Treatments Being Tested
The primary objective of this study was to assess the efficacy and safety o...
Status
Completed
Location
Department of Clinical Pharmacology
Start Date
2014-01-20
Trial ID
NCT02101281
Treatments Being Tested
The primary objective of this study was to assess the efficacy and safety o...
Status
Completed
Location
Penn Dry Eye and Ocular Surface Center, University of Pennsylvania
Start Date
2017-01-20
Trial ID
NCT03019627
This study is aimed at assessing the safety and the efficacy of two dose re...
Status
Completed
Location
CHU de Dijon - Service ophtalmologie
Start Date
2013-01
Trial ID
NCT01756456
Treatments Being Tested
Primary objectives * To compare the efficacy of cenegermin vs vehicle in S...
Status
Completed
Location
Lugene Eye Institute - Glendale Office
Start Date
2022-01-19
Trial ID
NCT05133180
Primary objective • To evaluate the efficacy of 5 μg/mL and 10 μg/mL conce...
Status
Completed
Location
Arizona Eye Center
Start Date
2024-01-22
Trial ID
NCT06244316
Treatments Being Tested
This study aims at investigating the therapeutic potential of recombinant h...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2015-05
Trial ID
NCT02609165
Treatments Being Tested
Primary Objective: To assess the efficacy of cenegermin-bkbj (20 mcg/mL) o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-26
Trial ID
NCT06411145
Treatments Being Tested
This is a phase 3, randomized, multicenter, double-masked, parallel group, ...
Status
Recruiting
Location
Azul Vision, INC
Start Date
2026-06-02
Trial ID
NCT07519902
Treatments Being Tested